Wednesday - November 18, 2026
SEC-FDA agreement heightens focus on life science disclosure and governance risks
November 17, 2026
KANSAS CITY, Missouri, Nov. 17 [Category: BizInsurance] -- Lockton, an insurance broker, posted the following news:

* * *

SEC-FDA agreement heightens focus on life science disclosure and governance risks

*

Key takeaways:

* A memorandum of understanding between the SEC and FDA expands information sharing, potentially making inconsistencies between regulatory communications and investor disclosures easier to identify.

* . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products